PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of jrsocmedLink to Publisher's site
 
J R Soc Med. 1987 July; 80(7): 418–421.
PMCID: PMC1290901

Experience with nalbuphine, a new opioid analgesic, in acute myocardial infarction.

Abstract

A total of 141 patients admitted to hospital with a diagnosis of suspected myocardial infarction were randomized to treatment with intravenous diamorphine (71) or nalbuphine (70). Myocardial infarction was subsequently confirmed in 109 patients. Both drugs provided good analgesia. Heart rate, blood pressure, respiratory rate, peak flow and minute volume were measured over a three-hour study period. Except for a slight fall in systolic blood pressure in the nalbuphine-treated group, there were no statistically significant differences between the groups. The nalbuphine-treated group had higher levels of aspartate aminotransferase and hydroxybutyric acid dehydrogenase but not creatine phosphokinase. The haemodynamic outcome and mortality at three months of the two groups were similar. It is concluded that nalbuphine provides effective analgesia coupled with few adverse circulatory or respiratory effects.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (720K), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Beaver WT, Feise GA. A comparison of the analgesic effect of intramuscular nalbuphine and morphine in patients with postoperative pain. J Pharmacol Exp Ther. 1978 Feb;204(2):487–496. [PubMed]
  • Tammisto T, Tigerstedt I. Comparison of the analgesic effects of intravenous nalbuphine and pentazocine in patients with postoperative pain. Acta Anaesthesiol Scand. 1977;21(5):390–394. [PubMed]
  • Romagnoli A, Keats AS. Ceiling effect for respiratory depression by nalbuphine. Clin Pharmacol Ther. 1980 Apr;27(4):478–485. [PubMed]
  • Lewis JR. Evaluation of new analgesics. Butorphanol and nalbuphine. JAMA. 1980 Apr 11;243(14):1465–1467. [PubMed]
  • Romagnoli Alexander, Keats Arthur S. COMPARATIVE HEMODYNAMIC EFFECTS OF NALBUPHINE AND MORPHINE IN PATIENTS WITH CORONARY ARTERY DISEASE. Cardiovasc Dis. 1978 Mar;5(1):19–24. [PMC free article] [PubMed]
  • Lee G, Low RI, Amsterdam EA, DeMaria AN, Huber PW, Mason DT. Hemodynamic effects of morphine and nalbuphine in acute myocardial infarction. Clin Pharmacol Ther. 1981 May;29(5):576–581. [PubMed]
  • Lake CL, Duckworth EN, DiFazio CA, Durbin CG, Magruder MR. Cardiovascular effects of nalbuphine in patients with coronary or valvular heart disease. Anesthesiology. 1982 Dec;57(6):498–503. [PubMed]
  • Jewitt DE, Maurer BJ, Hubner PJ. Increased pulmonary arterial pressures after pentazocine in myocardial infarction. Br Med J. 1970 Mar 28;1(5699):795–796. [PMC free article] [PubMed]
  • Lee G, DeMaria AN, Amsterdam EA, Realyvasquez F, Angel J, Morrison S, Mason DT. Comparative effects of morphine, meperidine and pentazocine on cardiocirculatory dynamics in patients with acute myocardial infarction. Am J Med. 1976 Jun;60(7):949–955. [PubMed]
  • Rickards AF, Smithen CS, Sowton E. Haemodynamic effects of pentazocine following acute myocardial infarction. Ann Clin Res. 1971 Aug;3(4):199–203. [PubMed]

Articles from Journal of the Royal Society of Medicine are provided here courtesy of Royal Society of Medicine Press